LVW Advisors »

Bridgebio Pharma shares owned by LVW Advisors

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by LVW Advisors from 13F filings

Historical chart of LVW Advisors investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by LVW Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by LVW Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $236k 4.5k 51.94
2025-06-30 $202k 4.7k 43.18

More positions owned by LVW Advisors

Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Ishares Tr 0-5 Yr Tips Etf (STIP)
Capital Group Gbl Growth Eqt Shs Creation Uni (CGGO)
Apple (AAPL)
Vanguard Bd Index Fds Intermed Term (BIV)
Vanguard Index Fds Growth Etf (VUG)
NVIDIA Corporation (NVDA)
Ab Active Etfs Tax Aware Interm (TAFM)
Capital Group International SHS (CGIE)
Spdr Series Trust Portfolio S&p500 (SPLG)
Ishares Tr Shrt Nat Mun Etf (SUB)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)

View all positions for LVW Advisors

Top funds holding Bridgebio Pharma

Vanguard Group
Viking Global Investors
BlackRock
Kohlberg Kravis Roberts & Co
Henderson Group
Farallon Capital Management
UBS Group
Aisling Capital Management
State Street Corporation
Jane Street
Susquehanna International
Invesco
Geode Capital Management
Frazier Life Sciences Management
Two Sigma Investments

View all funds holding Bridgebio Pharma